• 1:中国医师协会心血管内科医师分会结构性心脏病专业委员会

摘要(Abstract)：

<正>经导管主动脉瓣置换术(transcatheter aortic valvereplacement,TAVR)在我国经过十余年的发展,目前已进入崭新而关键的阶段[1]。2018年,我国首部理论与实践相结合的全流程TAVR临床路径《中国经导管主动脉瓣置换术临床路径专家共识》[2]应时而生,对我国近年来TAVR开展发挥了重要指导作用。首版临床路径问世3年来,TAVR领域在循证证据、应用经验、指南更新、器械研发、术式改良等方面陆续取得重要进展。为进一步紧贴最新证据经验,切实提高我国TAVR能力,推进TAVR规范、安全、健康地发展,特更新此版临床路径专家共识。

关键词(KeyWords)： 经导管主动脉瓣置换术;临床评估;影像学评估;规范化手术流程;围术期管理

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划资助主动健康和老龄化科技应对专项老年瓣膜性心脏病标准评估体系及优化治疗路径研究（2020YFC2008100）

作者(Author):

参考文献(References)：

• [1]中国医师协会心血管内科医师分会结构性心脏病专业委员会.经导管主动脉瓣置换术中国专家共识(2020更新版)[J].中国介入心脏病学杂志,2020,28(6):301-309.
• [2]中华医学会心血管病学分会结构性心脏病学组,中国医师协会心血管内科医师分会结构性心脏病专业委员会.中国经导管主动脉瓣置换术临床路径专家共识[J].中国循环杂志,2018,33(12):1162-1169.
• [3]Holmes DR Jr,Rich JB,Zoghbi WA,et al.The heart team of cardiovascular care[J].J Am Coll Cardiol,2013,61(9):903-907.
• [4]Yu Z,Zhao Q,Ye Y,et al.Comprehensive geriatric assessment and exercise capacity in cardiac rehabilitation for patients referred to transcatheter aortic valve implantation[J].Am J Cardiol,2021,158:98-103.
• [5]Mack MJ,Leon MB,Thourani VH,et al.Transcatheter aortic-valve replacement with a balloon-expandable valve in lowrisk patients[J].N Engl J Med,2019,380(18):1695-1705.
• [6]Popma JJ,Deeb GM,Yakubov SJ,et al.Transcatheter aorticvalve replacement with a self-expanding valve in low-risk patients[J].N Engl J Med,2019,380(18):1706-1715.
• [7]Otto CM,Nishimura RA,Bonow RO,et al.2020 ACC/AHA guideline for the management of patients with valvular heart disease:executive summary:a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines[J/OL].Circulation,2021,143(5):e35-e.71.
• [8]Vahanian A,Beyersdorf F,Praz F,et al.2021 ESC/EACTS guidelines for the management of valvular heart disease[J/OL].Eur Heart J,2021,ehab395.
• [9]Yoon SH,Bleiziffer S,De Backer O,et al.Outcomes in transcatheter aortic valve replacement for bicuspid versus tricuspid aortic valve stenosis[J].J Am Coll Cardiol,2017,69(21):2579-2589.
• [10]Luo X,Wang X,Li X,et al.Transapical transcatheter aortic valve implantation using the J-Valve system:a 1-year follow-up study[J].J Thorac Cardiovasc Surg,2017,154(1):46-55.
• [11]Yoon SH,Schmidt T,Bleiziffer S,et al.Transcatheter aortic valve replacement in pure native aortic valve regurgitation[J].J Am Coll Cardiol,2017,70(22):2752-2763.
• [12]Cerillo AG,Mariani M,Berti S,et al.Sizing the aortic annulus[J].Ann Cardiothorac Surg,2012,1(2):245-256.
• [13]Blanke P,Weir-McCall JR,Achenbach S,et al.Computed tomography imaging in the context of transcatheter aortic valve implantation(TAVI)/transcatheter aortic valve replacement(TAVR):an expert consensus document of the society of cardiovascular computed tomography[J].JACC Cardiovasc Imaging,2019,12(1):1-24.
• [14]Liu X,He Y,Zhu Q,et al.Supra-annular structure assessment for self-expanding transcatheter heart valve size selection in patients with bicuspid aortic valve[J].Catheter Cardiovasc Interv,2018,91(5):986-994.
• [15]Kurra V,Kapadia SR,Tuzcu EM,et al.Pre-procedural imaging of aortic root orientation and dimensions:comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography[J].JACC Cardiovasc Interv,2010,3(1):105-113.
• [16]Nakatani S.Subclinical leaflet thrombosis after transcatheter aortic valve implantation[J].Heart,2017,103(24):1942-1946.
• [17]Zhao ZG,Wang MY,Jilaihawi H.Imaging evaluation for the detection of leaflet thrombosis after transcatheter aortic valve replacement[J].Interv Cardiol Clin,2018,7(3):293-299.
• [18]Doherty JU,Kort S,Mehran R,et al.ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 appropriate use criteria for multimodality imaging in valvular heart disease:a report of the American College of Cardiology appropriate use criteria task force,American Association for Thoracic Surgery,American Heart Association,American Society ofEchocardiography,American Society of Nuclear Cardiology,Heart Rhythm Society,Society for Cardiovascular Angiography and Interventions,Society of Cardiovascular Computed Tomography,Society for Cardiovascular Magnetic Resonance,and Society of Thoracic Surgeons[J].J Nucl Cardiol,2017,24(6):2043-2063.
• [19]Nishimura RA,O'Gara PT,Bavaria JE,et al.2019 AATS/ACC/ASE/SCAI/STS expert consensus systems of care document:a proposal to optimize care for patients with valvular heart disease:a joint report of the American Association for Thoracic Surgery,American College of Cardiology,American Society of Echocardiography,Society for Cardiovascular Angiography and Interventions,and Society of Thoracic Surgeons[J].J Am Coll Cardiol,2019,73(20):2609-2635.
• [20]Bavaria JE,Tommaso CL,Brindis RG,et al.2018 AATS/ACC/SCAI/STS expert consensus systems of care document:operator and institutional recommendations and requirements for transcatheter aortic valve replacement:a joint report of the American Association for Thoracic Surgery,American College of Cardiology,Society for Cardiovascular Angiography and Interventions,and Society of Thoracic Surgeons[J].J Am Coll Cardiol,2019,73(3):340-374.
• [21]Dvir D,Jhaveri R,Pichard AD.The minimalist approach for transcatheter aortic valve replacement in high-risk patients[J].JACC Cardiovasc Interv,2012,5(5):468-469.
• [22]Butala NM,Chung M,Secemsky EA,et al.Conscious sedation versus general anesthesia for transcatheter aortic valve replacement:variation in practice and outcomes[J].JACC Cardiovasc Interv,2020,13(11):1277-1287.
• [23]Thiele H,Kurz T,Feistritzer HJ,et al.General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation:the randomized SOLVE-TAVI trial[J].Circulation,2020,142(15):1437-1447.
• [24]Toggweiler S,Gurvitch R,Leipsic J,et al.Percutaneous aortic valve replacement:vascular outcomes with a fully percutaneous procedure[J].J Am Coll Cardiol,2012,59(2):113-118.
• [25]Schymik G,Würth A,Bramlage P,et al.Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis[J/OL].Circ Cardiovasc Interv,2015,8(1):e000.761.
• [26]宋光远,刘新民,滕思勇,等.使用左心室导丝起搏技术行经导管主动脉瓣置换术[J].中华心血管病杂志,2021,49(5):461-466.
• [27]Grube E,Naber C,Abizaid A,et al.Feasibility of transcatheter aortic valve implantation without balloon pre-dilation:a pilot study[J].JACC Cardiovasc Inter v,2011,4(7):751-757.
• [28]Genereux P,Head SJ,Van Mieghem NM,et al.Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions:a weighted meta-analysis of 3,519 patients from 16 studies[J].J Am Coll Cardiol,2012,59(25):2317-2326.
• [29]Kappetein AP,Head SJ,Genereux P,et al.Updated standardized endpoint definitions for transcatheter aortic valve implantation:the valve academic research consortium-2 consensus document[J].Eur Heart J,2012,33(19):2403-2418.
• [30]Rodes-Cabau J,Kahlert P,Neumann FJ,et al.Feasibility and exploratory efficacy evaluation of the embrella embolic deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement:the PROTAVI-C pilot study[J].JACC Cardiovasc Interv,2014,7(10):1146-1155.
• [31]Rodes-Cabau J,Ellenbogen KA,Krahn AD,et al.Managementof conduction disturbances associated with transcatheter aortic valve replacement:JACC scientific expert panel[J].J Am Coll Cardiol,2019,74(8):1086-1106.
• [32]Tarantini G,Mojoli M,Purita P,et al.Unravelling the(arte)fact of increased pacemaker rate with the Edwards SAPIEN 3valve[J].EuroIntervention,2015,11(3):343-350.
• [33]De Backer O,Arnous S,Sandholt B,et al.Safety and efficacy of using the viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation[J].Am J Cardiol,2015,115(8):1123-1129.
• [34]Ribeiro HB,Webb JG,Makkar RR,et al.Predictive factors,management,and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation:insights from a large multicenter registry[J].J Am Coll Cardiol,2013,62(17):1552-1562.
• [35]Genereux P,Head SJ,Hahn R,et al.Paravalvular leak after transcatheter aortic valve replacement:the new Achilles' heel?A comprehensive review of the literature[J].J Am Coll Cardiol,2013,61(11):1125-1136.
• [36]Takagi K,Latib A,Al-Lamee R,et al.Predictors of moderateto-severe paravalvular aortic regurgitation immediately after Core Valve implantation and the impact of postdilatation[J].Catheter Cardiovasc Interv,2011,78(3):432-443.
• [37]Moat NE,Ludman P,de Bekder MA,et al.Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis:the U.K.TAVI(United Kingdom transcatheter aortic valve implantation)registry[J].J Am Coll Cardiol,2011,58(20):2130-2138.
• [38]Maisano F,Taramasso M,Nietlispach F.Prognostic influence of paravalvular leak following TAVI:is aortic regurgitation an active incremental risk factor or just a mere indicator[J]?Eur Heart J,2015,36(7):413-415.
• [39]Song G,Jilaihawi H,Wang M,et al.Severe symptomatic bicuspid and tricuspid aortic stenosis in China:characteristics and outcomes of transcatheter aortic valve replacement with the venus-A valve[J].Structural Heart,2017,2(1):60-68.
• [40]Kolte D,Khera S,Vemulapalli S,et al.Outcomes following urgent/emergent transcatheter aortic valve replacement:insights from the STS/ACC TVT registry[J].JACC Cardiovasc Interv,2018,11(12):1175-1185.
• [41]Besis G,Dimitrakakis G,Chetty G,et al.Aortic stenosis presenting with cardiogenic shock.Is there a role for intra-aortic balloon pump use[J]?Hellenic J Cardiol,2020,61(6):447-449.
• [42]Husser O,Holzamer A,Philipp A,et al.Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation[J/OL].Catheter Cardiovasc Interv,2013,82(4):E542-E551.
• [43] Babaliaros V,Devireddy C,Lerakis S,et al.Comparison of transfemoral transcatheter aortic valve replacement performedin the catheterization laboratory(minimalist approach)versus hybrid operating room(standard approach):outcomes and cost analysis[J].JACC Cardiovase Interv,2014,7(8):898-904.
• [44]Kotronias RA,Teitelbaum M,Webb JG,et al.Early versus standard discharge after transcatheter aortic valve replacement:a systematic review and meta-analysis[J].JACC Cardio vasc Interv,2018,11(17):1759-1771.
• [45]Wood DA,Lauck SB,Cairns JA,et al.The Vancouver3M(multidisciplinary,multimodality,but minimalist)clinical pathway facilitates safe next-day discharge home at low-,medium-,and high-volume transfemoral transcatheter aortic valve replacement centers:The 3M TAVR study[J].JACC Cardiovasc Interv,2019,12(5):459-469.
• [46]Barbanti M.Early discharge after transcatheter aortic valve replacement:mature times[J].JACC Cardiovasc Interv,2019,12(5):431-432.
• [47]Faroux L,Guimaraes L,Wintzer-Wehekind J,et al.Coronary artery disease and transcatheter aortic valve replacement:JACC state-of-the-art review[J].J Am Coll Cardiol,2019,74(3):362-372.
• [48]Yudi MB,Sharma SK,Tang GHL,et al.Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement[J].J Am Coll Cardiol,2018,71(12):1360-1378.
• [49]Sabbah M,Engstr?m T,De Backer O,et al.Coronary assessment and revascularization before transcutaneous aortic valve implantation:an update on current knowledge[J].Front Cardiovasc Med,2021,8:654892.
• [50]Palmerini T,Chakravarty T,Saia F,et al.Coronary protection to prevent coronary obstruction during TAVR:a multicenter international registry[J].JACC Cardiovasc Interv,2020,13(6):739-747.
• [51]Mercanti F,Rosseel L,Neylon A,et al.Chimney stenting for coronary occlusion during TAVR:insights from the chimney registry[J].JACC Cardiovasc Interv,2020,13(6):751-761.
• [52]Palmer S,Child N,de Belder MA,et al.Left atrial appendage thrombus in transcatheter aortic valve replacement:incidence,clinical impact,and the role of cardiac computed tomography[J JACC Cardiovasc Interv,2017,10(2):176-184.
• [53]Attinger-Toller A,Maisano F,Senn O,et al.“One-stop shop”:safety of combining transcatheter aortic valve replacement and left atrial appendage occlusion[J].JACC Cardiovasc Interv,2016,9(14):1487-1495.
• [54]Latib A,Naganuma T,Abdel-Wahab M,et al.Treatment and clinical outcomes of transcatheter heart valve thrombosis[J/OL].Circ Cardiovasc Interv,2015,8(4):e001779.